Purpura - 88 Studies Found

Completed : Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
: Acquired Thrombotic Thrombocytopenic Purpura
: 2016-08-04
: Biological: caplacizumab
Recruiting : Influence of Extracorporeal Circulation During Cardiac Surgery on the Development of Postoperative Thrombotic Thrombocytopenic Purpura (TTP)
: Cardiac Surgery
: 2011-02-18
Active, not recruiting : Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
:
  • Thrombotic Microangiopathies
  • Thrombotic Thrombocytopenic Purpura : 2014-03-24
    : Other: Biological and imaging investigations From day 1 to day 3, specific blood tests will be performed
Terminated : Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
:
  • Thrombotic Microangiopathy
  • Thrombotic Thrombocytopenic Purpura<
    : 2008-07-30
    :
    • Drug: ARC 1779 Placebo ARC1779
Completed : A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
: Thrombotic Thrombocytopenic Purpura (TTP)
: 2025-08-12
: TAK-755 IV infusion
Completed : A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)
: Thrombotic Thrombocytopenic Purpura (TTP)
: 2025-08-12
: Participants in prophylaxis cohort will receive IV infusions of 40 IU/kg BAX 930 ORT during Period 1 and Period 2 and switch to BAX 930 SIN durin
Completed : Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP
: Idiopathic Thrombocytopenic Purpura
: 2025-08-12
: Once a week as a subcutaneous injection.The initial dose is 1 mcg/kg.
COMPLETED : Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
: Thrombotic Thrombocytopenic Purpura
: 2025-08-12
: Lyophilized powder for solution for injection.
<<< Previous